Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer

Lung cancer is currently the leading cause of cancer-related death in worldwide, non-small cell lung cancer (NSCLC) accounts for about 85% of all lung cancers. Surgery, platinum-based chemotherapy, molecular targeted agents and radiotherapy are the main treatment of NSCLC. With the strategies of tre...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Jiabei, Hu, Ying, Hu, Mingming, Li, Baolan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4538573/
https://www.ncbi.nlm.nih.gov/pubmed/26279307
http://dx.doi.org/10.1038/srep13110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4538573/
https://www.ncbi.nlm.nih.gov/pubmed/26279307
http://dx.doi.org/10.1038/srep13110

Ejemplares similares